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 INEQUITY IN REHABILITATION INTERVENTIONS AFTER  
HIP FRACTURE: A SYSTEMATIC REVIEW 
ABSTRACT 
Objective To determine the extent to which equity factors contributed to eligibility criteria of trials 
of rehabilitation interventions after hip fracture. We define equity factors as those that stratify 
healthcare opportunities and outcomes. 
Design Systematic search of MEDLINE, Embase, CINHAL, PEDro, Open Grey, BASE, and 
ClinicalTrials.gov for randomized controlled trials of rehabilitation interventions after hip fracture 
published between 1st January 2008 and 30th May 2018. Trials not published in English, secondary 
prevention or new models of service delivery (e.g. orthogeriatric care pathway) were excluded. 
Duplicate screening for eligibility, risk of bias (Cochrane Risk of Bias Tool), and data extraction 
(Cochrane’s PROGRESS-Plus framework). 
Results 23 published, 8 protocol, 4 registered ongoing randomized controlled trials (4,449 
participants) were identified. A total of 69 equity factors contributed to eligibility criteria of the 35 
trials. For more than 50% of trials, potential participants were excluded based on residency in a 
nursing home, cognitive impairment, mobility/functional impairment, minimum age, and/or 
nonsurgical candidacy. Where reported, this equated to the exclusion of 2,383 out of 8,736 (27.3%) 
potential participants based on equity factors. Residency in a nursing home and cognitive 
impairment were the main drivers of these exclusions.  
Conclusion The generalizability of trial results to the underlying population of frail older adults is 
limited. Yet this is the evidence base underpinning current service design. Future trials should 
include participants with cognitive impairment and those admitted from nursing homes. For those 
excluded, an evidence-informed reasoning for the exclusion should be explicitly stated. 
PROSPERO CRD42018085930 
  
 INTRODUCTION 
Equity in health refers to the prevention of unfair, avoidable differences in health arising from 
cultural exclusion, poor governance, or corruption.1-3Equity in access to healthcare is a founding 
principle of the National Health Service (NHS).4 Access is characterised by gaining entry into a 
healthcare system and the timely delivery of appropriate care.5 Entering a healthcare system for hip 
fracture is not a discretionary decision – hospital admission is almost always necessary.6 However, 
timely delivery of appropriate care is determined by competing demands for services. In the UK 
29% of patients with hip fracture wait longer than the recommended 36-hours for surgery.7 Access 
to rehabilitation including bed capacity, formal access criteria, and waiting times exhibits greater 
variation than access to surgery.8-10 
Patients enrolled in randomized controlled trials often have better outcomes than those not enrolled 
in trials.11 Indeed, trial enrolment presents patients with the opportunity to consider additional 
access to care. It is possible patients with equal needs do not make equal use of this opportunity.12 
Alternatively, they may not be offered this opportunity as trial access is determined by eligibility 
criteria. Of interest is whether such eligibility criteria systematically limits access for patient 
subgroups who may benefit from intervention and who face poor outcomes. Indeed, patients who 
present from nursing homes with multiple morbidities are often excluded from rehabilitation trials 
after hip fracture 13 and have higher rates of complications and death.14-16 These patients may have 
the most to gain from additional access to rehabilitation through trials.  
In 2008, the Darzi Review committed to support local quality improvement efforts through Best 
Practice Tariffs.17 Tariffs are assigned ‘where the evidence of what is best practice is clear and 
compelling’ and may lead to local prioritization to maximise reimbursement from Tariffs.17 The 
exclusion of patient subgroups from trials results in a dearth of clear and compelling evidence to 
improve care for these patients, limiting the case for a Best Practice Tariff. Therefore, services for 
these patients may be underprioritized leading to a potentially unfair distribution of disability and 
death.  
The aim of this systematic review is to describe equity factors in randomized controlled trials of 
rehabilitation interventions after hip fracture. We define equity factors as those that stratify 
healthcare opportunities and outcomes.1-3 The primary objective is to determine the role of equity 
factors in eligibility criteria of trials of rehabilitation interventions after hip fracture, since 
publication of the Darzi Review. Secondary objectives are to determine the role these factors have 
in baseline characteristics and subgroup analyses. 
METHODS 
Protocol and registration  
The protocol was registered on the International Register of Systematic Reviews (PROSPERO).18 
The protocol and review were reported in adherence to the Preferred Reporting Items for Systematic 
Review and Meta-analysis statement – Equity extension.19-23  
Eligibility criteria 
We included randomized controlled trials of rehabilitation interventions after hip fracture.  
Rehabilitation was defined as ‘a set of interventions designed to optimize functioning and reduce 
disability in individuals with health conditions in interaction with their environment’.24 We 
excluded trials of secondary prevention or new models of service delivery unless they included an 
evaluation of rehabilitation effectiveness. We excluded trials not in English due to financial 
constraints of employing an interpreter. We excluded nonrandomized studies, and those published 
before 1st January 2008 to reflect the period after publication of the Darzi Review.17 
 Information sources 
We searched electronic databases for published (MEDLINE, Embase, CINHAL, PEDro), 
unpublished (Open Grey, BASE), and registered ongoing trials (ClinicalTrials.gov) on 30th May 
2018. We searched reference lists of systematic reviews identified during electronic database 
searches. We contacted corresponding authors as required.  
Search 
We used published terms for the study population (hip fracture),25 intervention (rehabilitation),26 27 
and study design (randomized controlled trials).26 27 We supplemented published strategies with one 
additional term -‘exp Rehabilitation’ (Supplementary File 1).   
Study selection  
We imported citations into Covidence for de-duplication and screening.28 Where registration, 
protocol, and/or final publication were available for the same trial we retained the most recent 
source. Two reviewers independently screened abstracts, and full texts of potentially eligible 
studies, against eligibility criteria (R2, R3). Conflicts were resolved by a third reviewer (R1).  
Data extraction 
Two reviewers independently extracted data onto templates adapted from published extraction 
tables (R2, R3).29 30 Where published trials and secondary analyses of the same trial were available 
we extracted data from the published trial and data related to subgroup analyses from the secondary 
analysis. Data extraction included author’s name, publication year, country, sample size, sample 
characteristics, intervention, control, effect estimate.  
We extracted data for equity factors in eligibility criteria, baseline characteristics, and subgroup 
analyses. We defined equity factors by the Cochrane and Campbell Collaboration Equity Methods 
group’s PROGRESS-PLUS framework .3 23 We extracted justification for eligibility criteria where 
available.  
PROGRESS is an acronym for Place of residence, Race/ethnicity/language/culture, Occupation 
(e.g. retirement status), Gender, Religion, Education, Socioeconomic status, and Social Capital.1-3 
PLUS captures other factors which impact equity namely (1) age (2) disability (3) features of 
relationships, and (4) time-dependent relationships.1-3  
Risk of bias  
Three reviewers independently assessed risk of bias using the Cochrane Risk of Bias Tool which 
considers bias in selection, performance, detection, attrition, reporting, and other biases (e.g. usual 
care group does not reflect clinical practice) (R1, R2, R3).31 Conflicts were resolved by consensus.  
Synthesis of results 
We summarized study characteristics, and the extent to which equity factors are considered in 
eligibility criteria, baseline characteristics, and subgroup analyses, with counts and proportions in 
text, tables and figures. We defined ‘systematic exclusion’ as exclusion based on one equity factor 
in at least 50% of trials. We calculated counts and proportions of eligible patients excluded for 
equity factors that contributed to eligibility criteria in at least 50% of trials.  
Public and patient involvement 
Two reviewers led discussions with patients after hip fracture and their carers (n = 8) to inform the 
review rationale (R1, R4).  
 RESULTS 
Study selection 
We identified 4,348 articles after de-duplication. We excluded 4,224 on abstract screening. We 
excluded 85 on full text screening for: study design (n = 34), population (n = 9), intervention (n = 
18), language (n = 1), publication date (n = 24), leaving 38 trials included.(Figure 1).  
Study characteristics 
Detailed study characteristics for the 23 published,32-54 8 protocol,55-62 and 4 registered63-66 trials, 
and 3 secondary analyses of trials67-69 are presented in Supplementary File 2.52  
This review included 4,449 participants (sample size range 1151 to 400).55 Interventions included 
exercise (n = 23),34-37 39 40 42-50 52 53 55 58 59 63 65 66 physiotherapy (n = 7),32 41 51 54 56 57 62 occupational 
therapy (n = 3),38 56 61 electrical stimulation (n = 1),33 telerehabilitation (n = 1),64 and visual 
feedback on weight-bearing (n = 1).60 Interventions providers were physiotherapists (n = 20),32-37 41 
43 44 48-50 54 57-60 62 63 66 occupational therapists (n = 3),38 61 64 exercise trainers (n = 2),42 46 psychiatrists 
(n = 1),40 or a multi-disciplinary team (n = 5).39 45 52 53 56 Four studies did not specify intervention 
provider.47 51 55 65 Intervention settings included hospital (n = 11),34 35 38-40 45 47 51 55 56 60 home (n = 
8),36 37 42 44 50 58 59 64 hospital and home (n = 4),32 33 41 52 outpatients (n = 2),46 54 outpatients and home 
(n = 4),48 49 53 62 nursing homes (n = 2),57 61 and gyms (n = 1).43 Three studies did not specify 
intervention setting. 63 65 66  
Figure 1: Study selection 
 
  
 Risk of bias within studies 
Detailed risk of bias assignments are presented in Supplementary File 3. Lack of blinding of 
personnel and participants was the most common reason for high bias assignment (n = 17).33 35 37 40 
41 45 48 50 52-58 60 62 Additional reasons for high bias assignment included: allocation concealment (n = 
1),52 blinding outcome assessors (n = 1),45 and incomplete outcome data (n = 1).52  
Synthesis of results  
 
Eligibility criteria 
At least one PROGRESS-PLUS factor contributed to eligibility criteria in 34 (97.1%) trials (Figure 
2, Tables 1-2).32-46 48-66 Potential participants were excluded based on PROGRESS factors - place of 
residence, race, gender, education, socioeconomic status, and/or social capital and  PLUS factors –
time-dependent relationships, age, and disabilities. One trial did not specify eligibility criteria.47 
Occupation, religion, and features of relationships did not contribute to eligibility criteria. 
Figure 2: Contribution of equity factors to eligibility criteria, reporting of baseline 
characteristics, and subgroup analyses in randomized controlled trials of rehabilitation after 
hip fracture  
 
  
 Justification for eligibility criteria 
Fifteen (42.9%) trials included justification for at least one eligibility criteria.32 36 38 39 41 42 46 50 52 55 57 
58 60 64 65 Potential participants were excluded based on prefracture nursing home residence,38 timing 
of discharge from rehabilitation,38  time since fracture,38 aged less than 60-years or greater than 85-
years, organ failure,38 history of lower limb disorder,38 comorbidities that could affect gait,60 or 
cognitive impairment,38 to mitigate their potential to reduce the intervention effect. Potential 
participants were excluded based on language, vision, or hearing disabilities,39 and/or other 
comorbidities32 36 38 39 41 42 50 52 57 58 64 65 as they may limit intervention participation. Potential 
participants were excluded based on poor social support due to the cognitively vulnerable nature of 
the population.55 Potential participants were excluded based on cognitive impairment due to limited 
capacity for consent.46  
Potential participant exclusion counts and proportions  
Eighteen trials provided counts of potential participants excluded for criteria occurring in at least 
50% of trials.32-36 38-42 44 46 48 50 51 54 Seven studies excluded 760 of 3,952 (19.2%) potential 
participants admitted from a nursing home.34 35 38 42 44 48 50 Eleven studies excluded 740 of 6,549 
(11.3%) potential participants with cognitive impairment.32 33 36 38-42 44 46 51 Six studies excluded 380 
of 3,892 (9.8%) potential participants younger than the minimum age.35 46 48 50 52 54 Eight studies 
excluded 262 of 2,870 (9.1%) potential participants with mobility/functional impairment.32-34 41 50-52 
54 Two studies excluded 38 of 1,268 (3.0%) potential participants treated nonsurgically for hip 
fracture.32 54  
Baseline characteristics 
At least one PROGRESS-PLUS factor was reported in baseline characteristics in 23 published trials 
and 8 trial protocols (Figure 2, Tables 1-2).32-55 57-62 Religion and features of relationships were not 
reported. 
Subgroup analyses 
At least one PROGRESS-PLUS factor contributed to subgroup analyses in 1 (2.9%) published 
trial52 and 3 (8.8%) secondary analyses of published trials (Figure 2, Table 1-2).67-69 Subgroup 
analyses for gender, age, depression, balance confidence, nutrition, and cognition were planned in 
one protocol (Figure 2, Table 1-2).59  Further details on subgroup analysis are presented in 
Supplementary File 4. 
DISCUSSION 
Summary of evidence 
This review aimed to describe equity in randomized controlled trials of rehabilitation interventions 
after hip fracture. For more than 50% of the 35 trials, we identified exclusion of potential 
participants based on nursing home residency, cognitive impairment, mobility/functional 
impairment, minimum age, and/or nonsurgical candidacy. Where reported, this equated to exclusion 
of 2,383 of 8,736 (27.3%) potential participants based on equity factors. Nursing home residency 
and cognitive impairment were the main drivers, accounting for 1,500 excluded potential 
participants. 
Strengths and Limitations 
We used published search terms reviewed by a research librarian. We searched for published, 
unpublished, and registered trials to reduce the risk of publication bias. We used broad eligibility 
criteria, and duplicate screening for eligibility, bias assignment, and data abstraction to reduce the 
risk of selection bias. We used Cochranes recommended appraisal tool31 and framework for 
synthesis of equity factors.1-3 We did not search conference websites for proceedings which may 
have led to the exclusion of relevant trials. We searched for articles based on study design which 
 may have led to the exclusion of secondary subgroup analyses of trials. We excluded articles not 
published in English and trials of secondary prevention or new models of care which may 
incorporate components of rehabilitation. Exclusion of trials published before 1st January 2008 may 
have led to an underestimation of the proportion of trials with exclusion based on PROGRESS-
PLUS factors as earlier reviews reported exclusions based on minimum age, gender, comorbidities, 
cognitive impairment, and mobility impairment.27 70 We defined equity factors by the PROGRESS-
PLUS framework which does not incorporate medical inequities resulting from care quality. We did 
not extract the number of trials which incorporated public and patient involvement. Trials with 
involvement may see fewer cases of inequity.  
Interpretation 
Researchers define eligibility criteria to ensure feasibility while reducing potential for harm or 
exploitation of vulnerable potential participants.72 These criteria are often accompanied with a 
rationale when seeking ethical approval. This rationale rarely appears in protocols or publications. It 
is therefore unclear whether exclusions are employed based on (i) potential for benefit, (ii) 
feasibility of participation, (iii) feasibility of outcome measurement or (iv) target population. 
Potential for benefit 
In this review, 29 (82.9%) trials excluded potential participants based on cognitive impairment. This 
criterion does not seem appropriate as one in three patients with hip fracture have cognitive 
impairment.13 Planning services around reported intervention effectiveness is challenging as 
findings are not generalizable to a substantial proportion of the population. Further, patients with 
cognitive impairment demonstrate improved mobility, functional, and cognitive outcomes with 
intensive rehabilitation after hip fracture.13 73 Subgroup analysis for one trial in this review indicated 
greater improvement in mobility for those with lower than those with higher executive function.52 
Therefore, patients with cognitive impairment may have potential for benefit from additional access 
to rehabilitation enrollment in trials offer.   
One trial justified exclusion based on cognitive impairment - to mitigate their potential to reduce the 
intervention effect.38 This may be addressed with regression adjustment and subgroup analyses. 
Capacity for consent was also cited to justify exclusion based on cognitive impairment.46 This was 
overcome in two trials in this review.34 55 When patients were unable to provide consent, it was 
requested from persons responsible for their medical decisions34 or a suitable informant.55 
Therefore, we recommend any trial in the context of hip fracture should include those with 
cognitive impairment, and where they are excluded an evidence-informed reasoning should be 
stated. 
Feasibility of participation  
Trials may exclude potential participants as pragmatically they could not be supported to participate 
in the intervention within budget and/or time constraints. These constraints are important issues in 
any research but have implications for a trial’s potential cost-benefit when generalisability is 
limited. Where this occurs, and an intervention demonstrated efficacy, the design needs to be 
adapted (if possible) to maximise equity and evaluated through additional trials or service 
evaluations. These additional steps delay patient benefit. We reported exclusions on language, 
vision, or hearing disabilities,39 and/or comorbidities32 36 38 39 41 42 50 52 57 58 64 65 as they may limit 
participation in the intervention. One trial countered ‘may not be able to participate’ through 
engagement of staff and relatives to establish a controlled and protected environment which resulted 
in a low attrition rate.40 Careful consideration of intervention design is required prior to exclusion 
based on a perceived lack of potential for participation. Further, it may be argued a perceived lack 
of potential is an insufficient justification for exclusion, and an evidence-based reasoning be stated.  
 Feasibility of outcome measurement 
In the current review, 25 (71.4%) trials excluded potential participants with mobility/functional 
impairment. It is not clear whether feasibility of primary outcome measurement contributed to this 
exclusion criterion. For example, one trial which excluded participants unable to walk 10 metres 
prefracture selected the Short Physical Performance Battery.62 This trial included additional self-
reported mobility measures, falls, and frailty obtainable in potential participants unable to walk 10 
metres prefracture.  
Target population  
Inconsistencies in eligibility criteria may point to a lack of consensus of how best to define the 
target population. For example, 30 (85.7%) trials excluded potential participants based on a 
minimum age. Minimum ages included 55 -, 60 -, 65- , or 70- years highlighting a lack of 
consensus as to an appropriate minimum age, if one is needed at all. This minimum age may reflect 
efforts to capture a target population of ‘frail older adults’ to improve consistency in the probability 
of outcomes across participant groups. However, a recent cohort study indicated a 50% increase in 
walking aid use 1-year after hip fracture for adults aged less than 60 years.77 In addition, one trial 
included in the current review reported improvements in functional outcomes among adults aged 
60-79 years compared to those aged greater than 79 years.67 Therefore, excluding potential 
participants based on a minimum age reduces access for patients who may benefit from the 
intervention and who face poor outcomes.  
In some cases, exclusion of potential participants based on a target population may be justified. For 
example, it may be reasonable for a community-based intervention to be trialled in participants who 
reside in the community. In the current review, 21 trials included post-acute rehabilitation. Of these, 
19 were completed in the community (home, outpatients, senior’s gym). Only 2 trials were 
completed in nursing homes. It could be argued these interventions contribute to relative 
discrimination denying access to additional rehabilitation for those with higher needs.78  Indeed, in 
the UK only 70% of hospitals have access to physiotherapy follow-up in nursing homes where 
therapy input is already limited across residents.7 Systematically excluding those who likely incur 
the greatest healthcare costs will fail to generate the health economic evidence base required to 
change healthcare funding for these individuals. 
Conclusions 
We identified systematic exclusion of potential participants from rehabilitation trials after hip 
fracture based on equity factors that stratify healthcare opportunities and outcomes. We suggest 
randomized controlled trials of rehabilitation after hip fracture should be designed considering 
equity of access to the additional care trial enrolment provides. In particular, we suggest trials 
should have a clearly defined target population and consent process with broad eligibility criteria 
(inclusive of potential participants with cognitive impairment and those admitted from nursing 
homes) to maximise generalisability to the underlying population of frail older adults. Primary 
outcome measures should facilitate participation to reduce bias from missing data by considering 
their accessibility, and both floor and ceiling effects. We propose researchers target a range of 
treatment settings (community and nursing homes) to further reduce potential inequities. For each 
exclusion criteria, an evidence-informed reasoning for the exclusion should be explicitly stated. 
This reasoning should indicate a clear potential for harm (e.g. mobilisation in participants treated 
conservatively), or a specific description of why excluded potential participants could not be 
supported to participate within budget/time constraints.   
REFERENCES 
1. Evans T, Brown H. Road traffic crashes: operationalizing equity in the context of health sector 
reform. Injury Control and Safety Promotion 2003;10(1-2):11-12.  
 2. Oliver S, Kavanagh J, Caird J, et al Health promotion, inequalities and young people’s health: a 
systematic review of research. 2008. London: EPPI-Centre, Social Science Research Unit, 
Institute of Education, University of London. 
3. O'Neill J, Tabish H, Welch V, et al. Applying an equity lens to interventions: using PROGRESS 
ensures consideration of socially stratifying factors to illuminate inequities in health. Journal of 
Clinical Epidemiology 2014;67(1):56-64.  
4. Judge A, Welton NJ, Sandhu J, et al. Equity in access to total joint replacement of the hip and 
knee in England: cross sectional study. BMJ 2010;341:c4092. 
5. Williams JA, Byles JE, Inder KJ. Equity of access to cardiac rehabilitation: the role of system 
factors. Int J Equity Health 2010;9:2.  
6. Wennberg JE. Tracking medicine : a researcher's quest to understand health care. New York: 
Oxford University Press 2010. 
7. Royal College of Physicians. National Hip Fracture Database annual report 2017. London: RCP, 
2017. 
8. Neuburger J, Harding KA, Bradley RJ, et al. Variation in access to community rehabilitation 
services and length of stay in hospital following a hip fracture: a cross-sectional study. BMJ 
Open 2014;4(9):e005469. 
9. Drew S, Sheard S, Chana J, et al. Describing variation in the delivery of secondary fracture 
prevention after hip fracture: an overview of 11 hospitals within one regional area in England. 
Osteoporos Int 2014;25(10):2427-33. 
10. Royal College of Physicians. Recovering after a hip fracture: helping people understand 
physiotherapy in the NHS. Physiotherapy ‘Hip Sprint’ audit report 2017. London: RCP, 2018. 
11. McCarney R, Warner J, Iliffe S, et al. The Hawthorne Effect: a randomised, controlled trial. 
BMC Med Res Methodol 2007;7:30. doi: 10.1186/1471-2288-7-30 
12. Oliver A, Mossialos E. Equity of access to health care: outlining the foundations for action. J 
Epidemiol Community Health 2004;58(8):655-8. 
13. Mundi S, Chaudhry H, Bhandari M. Systematic review on the inclusion of patients with 
cognitive impairment in hip fracture trials: a missed opportunity? Can J Surg 2014;57(4):E141-
5. 
14. Sheehan KJ, Sobolev B, Chudyk A, et al. Patient and system factors of mortality after hip 
fracture: a scoping review. BMC musculoskeletal disorders 2016;17:166.  
15. Smith T, Pelpola K, Ball M, et al. Pre-operative indicators for mortality following hip fracture 
surgery: a systematic review and meta-analysis. Age and ageing 2014;43(4):464-71. doi: 
10.1093/ageing/afu065  
16. Sheehan KJ, Williamson L, Alexander J, et al. Prognostic factors of functional outcome after 
hip fracture surgery: a systematic review. Age and ageing 2018;47(5):661-70. doi: 
10.1093/ageing/afy057  
17. Gershlick B. Best Practice Tariffs. Country Background Note: United Kingdom (England). The 
Health Foundation 2016. Available at: https://www.oecd.org/els/health-systems/Better-Ways-to-
Pay-for-Health-Care-Background-Note-England-Best-practice-tariffs.pdf, [Accessed on October 
17th 2018] 
18. (PROSPERO) International prospective register of systematic reviews. 
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=85930 2018. [Accessed on 
October 17th 2018] 
19. Welch V, Petticrew M, Petkovic J, et al. Extending the PRISMA statement to equity-focused 
systematic reviews (PRISMA-E 2012): explanation and elaboration. International Journal for 
Equity in Health 2015;14(1):92.  
 20. Welch V, Petticrew M, Tugwell P, et al. PRISMA-Equity 2012 Extension: Reporting 
Guidelines for Systematic Reviews with a Focus on Health Equity. PLOS Medicine 
2012;9(10):e1001333. 
21. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic 
reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and 
elaboration. BMJ 2009;339 
22. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and 
meta-analyses: the PRISMA statement. BMJ 2009;339  
23. Tugwell P, Petticrew M, Kristjansson E, et al. Assessing equity in systematic reviews: realising 
the recommendations of the Commission on Social Determinants of Health. BMJ 2010;341 
24. World Health Organisation. Rehabilitation in health systems. 2017. Available at: 
http://apps.who.int/iris/bitstream/handle/10665/254506/9789241549974-
eng.pdf;jsessionid=18DF8F518ED956AA5FF9D8772E365298?sequence=1 [Accessed on 
October 17th 2018] 
25. Parker MJ, Handoll HHG. Replacement arthroplasty versus internal fixation for extracapsular 
hip fractures in adults. Cochrane Database of Systematic Reviews 2006(2) doi: 
10.1002/14651858.CD000086.pub2 
26. Handoll HHG, Cameron ID, Mak JCS, et al. Multidisciplinary rehabilitation for older people 
with hip fractures. Cochrane Database of Systematic Reviews 2009(4) doi: 
10.1002/14651858.CD007125.pub2 
27. Crotty M, Unroe K, Cameron ID, et al. Rehabilitation interventions for improving physical and 
psychosocial functioning after hip fracture in older people. Cochrane Database of Systematic 
Reviews 2010(1) doi: 10.1002/14651858.CD007624.pub3 
28. Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. 
Available at www.covidence.org [Accessed on October 17th 2018] 
29. Attwood S, van Sluijs E, Sutton S. Exploring equity in primary-care-based physical activity 
interventions using PROGRESS-Plus: a systematic review and evidence synthesis. International 
Journal of Behavioral Nutrition and Physical Activity 2016;13(1):60.  
30. Lehne G, Bolte G. Impact of universal interventions on social inequalities in physical activity 
among older adults: an equity-focused systematic review. International Journal of Behavioral 
Nutrition and Physical Activity 2017;14(1):20. 
 
For full reference list please see supplementary file 5  
  
 Table 1: Contribution of PROGRESS-PLUS equity factors to eligibility criteria, reporting of baseline characteristics, and subgroup analyses 
in randomized controlled trials of rehabilitation after hip fracture.  
 Exclusion criteria Baseline characteristics* Subgroup analysis† 
 n (%) references n (%) references n (%) references 
Total  35 (100)  31 (100)  34 (100)  
PROGRESS-PLUS factors‡          
Place of residence          
admitted from nursing home  18 (51.4) 34 35 37 38 41 43 44 48-50 53 
54 57-59 61 62 65 
7 (22.6) 32 34 36 41 46 53 55    
admitted from assisted living    6 (19.4) 32 34 36 39 41 46    
admitted from community  1 (2.9) 51 8 (25.8) 32 34 36 39 41 46 53 55    
admitted from hospital/rehabilitation    2 (6.5) 53 55    
outside trial catchment area 11 (31.4) 32 36 43-45 48-51 53 54       
discharge to nursing home 7 (20.0) 41 48 49 54 61 62 64 2 (6.5) 35 42    
discharge to community 1 (2.9) 41 2 (6.5) 35 42    
discharge to rehabilitation     2 (6.5) 35 42    
definition not specified     2 (6.5) 54 59    
Race/ethnicity/ language/culture          
white    3 (9.7) 36 42 46    
language barrier 11 (31.4) 32 35 36 38-40 46 53 54 57 64       
definition not specified     1 (3.2) 59    
Occupation          
employment status    1 (3.2) 40    
Gender          
gender 2 (5.7) 42 51 23 (74.2) 32-38 40 41 44-50 52-54 57 59-61 3 (8.8) 59 67 69 
Education          
none    3 (9.7)     
primary    4 (12.9)     
secondary     4 (12.9)     
tertiary    5 (16.1) 36 40 42 45 47    
low technology literacy 1 (2.9) 64       
definition not specified    2 (6.5) 57 59    
Socioeconomic status          
 insurance    1 (3.2) 34    
income    1 (3.2) 47    
internet at home 1 (2.9) 64       
Social capital          
living with other people 1 (2.9) 61 12 (38.7) 36 37 39 46 48-50 52-54 57 59    
marital status    7 (22.6) 37 40 42 45 47 59 61    
no social support 3 (8.6) 41 55 64 4 (12.9) 34 41 46 53    
use of rehabilitation services 1 (2.9) 36 1 (3.2) 60    
use of home/community services    3 (9.7) 41 46 53    
PLUS: time dependent relationships          
time since fracture 5 (14.3) 36 42 43 58 62 8 (25.8) 36 37 39-41 43 52 61    
time since admission 1 (2.9) 59       
time since surgery 5 (14.3) 33 37 40 55 66 2 (6.5) 33 44    
time since hospital discharge 2 (5.7) 63 65       
time since rehabilitation discharge  2 (5.7) 36 38       
time on study ward 1 (2.9) 55       
readmit within 2 weeks of discharge 1 (2.9) 60       
expected rehabilitation duration 4 (11.4) 52 60 61 63       
actual rehabilitation duration    1 (3.2) 60    
length of hospital stay    6 (19.4) 35 38 39 42 45 55    
PLUS: age          
age    27 (87.1) 32-54 57 59-61 2 (5.9) 59 67 
minimum age 30 (85.7) 32-37 40 42-46 48-50 52-66       
maximum age 2 (5.7) 43 66       
PLUS: disability          
Disability (See Table 2) 34 (97.1)  30 (96.8)  3 (8.8)  
*excludes 4 registered randomized controlled trials and 3 secondary analyses of randomized controlled trials 
†excludes 4 registered randomized controlled trials 
‡religion and features of relationships did not contribute to eligibility criteria, reporting of baseline characteristics, or subgroup analyses in any 
randomized controlled trial of rehabilitation after hip fracture   
 
  
 Table 2: Contribution of the PLUS equity factor of disability to eligibility criteria, reporting of baseline characteristics, and subgroup analyses 
in randomized controlled trials of rehabilitation after hip fracture.  
 Exclusion criteria Baseline characteristics* Subgroup analysis† 
 n (%) references n (%) references n (%) references 
Total  35 (100)  31 (100)  34 (100)  
PLUS: Disability          
          
Patient-related          
          
cognitive impairment 29 (82.9) 32 33 36-42 44 45 48 49 
51-66 
21 (67.7) 32 34-37 39-41 46-48 
50-52 54 55 57 58 61 
62 67 
2 (5.9) 52 59 
no capacity for consent 9 (25.7) 35 44 46 51 52 54 57 61 
65 
      
unwilling/unable to participate 4 (11.4) 32 35 56 63       
          
mobility/functional impairment 23 (65.7) 32-37 41-45 50-52 57-60 
62-66 
24 (77.5) 33 34 36 37 39 41 44-
46 48-55 57-62 67 
2 (5.9) 52 68 
low activity tolerance 2 (5.7) 41 52       
balance confidence/falls    9 (29.0) 32 35 41 46 50 57 58 
61 62 
1 (2.9) 59 
medical condition limiting exercise 11 (31.4) 32 36 39 41 50 52 57 58 
62 64 65 
      
          
depression 4 (11.4) 36 44 53 64 9 (29.0) 36 37 39 42 46 54 58 
62 67 
1 (2.9) 59 
severe mental illness 2 (5.7) 53 64       
          
alcoholism 4 (11.4) 32 43 44 53       
drug abuse 1 (2.9) 53 1 (3.2) 40    
smoker    1 (3.2) 40    
psychosocial problems    2 (6.5) 55 61    
          
visual disability 5 (14.3) 32 36 39 52 58 1 (3.2) 46    
 hearing disability 4 (11.4) 32 33 39 58       
communication disability 2 (5.7) 58 64       
          
comorbidities‡§ 18 (51.4) 32 33 35-37 40 42-44 56 
58 60 63-66 
16 (51.6) 32 36 37 39-44 46 51-
53 57 60 62 
   
nutrition    2 (6.5) 46 58 1 (2.9) 59 
BMI    9 (29.0) 32 33 37-40 44 52 62    
medications    5 (16.1) 39 41 46 52 58    
          
Injury-related          
          
multiple fractures 5 (14.3) 35 48 49 56 66       
bilateral hip fracture 3 (8.6) 36 39 45       
complications¥** 5 (14.3) 33 39 40 58 66 33 39 66 7 (22.6) 36 37 40 42 46 52 62    
          
pathological hip fracture/ cancer  10 (28.6) 32 34 36 37 42 46 48-50 
56 57 59 66 
2 (6.5) 36 42    
terminal illness/reduced life expectancy 14 (40.0) 33 35-37 45 46 48 50 53 
55 57 61 63 
      
nonsurgical candidacy 19 (54.3) 32-35 37 40-42 44-46 50 
53-55 57-59 65 
      
ADL = activities of daily living; BMI = body mass index 
*excludes 4 registered randomized controlled trials and 3 secondary analyses of randomized controlled trials †excludes 4 registered randomized controlled trials ‡exclusion based on 
neurological disease,36 37 42 43 58 64-66 cardiac disease,33 36 37 42 44 previous hip surgery,32 35 40 42 58 pulmonary disease,36 42 44 renal disease,32 37 42 other progressive disease,43 44 history of 
stroke,37 40 amputated lower limb,43 bone disease,42 history of lower limb trauma,38 hip surgery for infection/arthritis,56 lower limb sensory neuropathy,37 body weight greater than 120 
kg,60 conditions that increased the risk of falling,42 gait impairment not related to hip fracture,63 organ failure,38 systemic disorders,40 creatinine clearance of <15mL/min,32 
hypercalcemia,32 primary hyperparathyroidism or sarcoidosis,32 liver cirrhosis42 and/or acute vertigo.58 §baseline characteristics include cardiac disease40 42 endocrine disease36 40 42 46 
52, bone disease42 46 62 osteoarthritis36 46, ‘other comorbidities’ (no other information provided)32 37 39-44 46 51-53 57 60 62 ¥ exclusion based on cardiac and 33 39 40 58 66 respiratory33 39 66 
complications ** baseline characteristics include complications62 cardiovascular complications36 37 42 46 52, pulmonary complications36 42 46 52 neurological complications46 52 
gastrointestinal complications42 52 urogenital complications52 62, lower limb complications42 52, renal complications40 42
  
